PRESS STATEMENT: FDA Approves Praluent, New Cholesterol-Lowering Treatment
Jul 24, 2015
“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but it’s price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years.” Read More
